Patents by Inventor Billy Law

Billy Law has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210290682
    Abstract: Described herein are novel preparations of functionalized erythroid cells and related compositions, reagents, and methods for use in human pharmaceutical and veterinary applications.
    Type: Application
    Filed: May 27, 2021
    Publication date: September 23, 2021
    Applicant: Rubius Therapeutics, Inc.
    Inventors: Thomas Wickham, Tiffany Fen-Yi Chen, Xuqing Zhang, Carolyn Sayre, Jordi Mata-Fink, Sivan Elloul, Billy Law, Lenka Hoffman, Kristian Eric Teichert, Shamael Rabia Dastagir
  • Patent number: 11020435
    Abstract: Described herein are novel preparations of functionalized erythroid cells and related compositions, reagents, and methods for use in human pharmaceutical and veterinary applications.
    Type: Grant
    Filed: February 16, 2018
    Date of Patent: June 1, 2021
    Assignee: Rubius Therapeutics, Inc.
    Inventors: Tom Wickham, Tiffany F. Chen, Xuqing Zhang, Carolyn Sayre, Jordi Mata-Fink, Sivan Elloul, Billy Law, Lenka Hoffman, Kristian Eric Teichert, Shamael Rabia Dastagir
  • Publication number: 20210147802
    Abstract: Provided herein are methods of generating a population of enucleated erythroid cells.
    Type: Application
    Filed: November 4, 2020
    Publication date: May 20, 2021
    Inventors: Billy Law, Alan Benjamin Gilbert
  • Publication number: 20210130780
    Abstract: Provided herein are methods of generating a population of enucleated erythroid cells.
    Type: Application
    Filed: November 4, 2020
    Publication date: May 6, 2021
    Inventors: Billy Law, Alan Benjamin Gilbert
  • Publication number: 20190201548
    Abstract: The disclosure provides, e.g., modified enucleated erythroid cells having increased or decreased levels of particular endogenous proteins. For example, CD47-negative enucleated erythroid cells may be used to induce tolerance to an exogenous antigen.
    Type: Application
    Filed: December 28, 2018
    Publication date: July 4, 2019
    Inventors: Avak Kahvejian, Jordi Mata-Fink, Billy Law
  • Publication number: 20180344770
    Abstract: Described herein are novel preparations of functionalized erythroid cells and related compositions, reagents, and methods for use in human pharmaceutical and veterinary applications.
    Type: Application
    Filed: February 16, 2018
    Publication date: December 6, 2018
    Inventors: Tom Wickham, Tiffany F. Chen, Xuqing Zhang, Carolyn Hudak, Jordi Mata-Fink, Sivan Elloul, Billy Law, Lenka Hoffman, Kristian Eric Teichert, Shamael Rabia Dastagir